Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
about
The retinoid X receptors and their ligandsAlitretinoin for the treatment of severe chronic hand eczemaSystemic therapy for atopic dermatitisThe key role of aquaporin 3 and aquaporin 10 in the pathogenesis of pompholyxSystematic review of cost-of-illness studies in hand eczema.Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema--a long-term analysis from a Swiss perspective.Hand eczemaAcitretin as a Therapeutic Option for Chronic Hand EczemaUpdate on the use of alitretinoin in treating chronic hand eczema.Use of Longitudinal Dose-Response Modeling to Support the Efficacy and Tolerability of Alitretinoin in Severe Refractory Chronic Hand Eczema (CHE).Use of 308 nm excimer laser for the treatment of chronic hand and foot eczema.Identification, synthesis, and biological evaluation of the metabolites of 3-amino-6-(3'-aminopropyl)-5H-indeno[1,2-c]isoquinoline-5,11-(6H)dione (AM6-36), a promising rexinoid lead compound for the development of cancer chemotherapeutic and chemoprAlitretinoin in Dermatology-An Update.Patterns of chronic hand eczema: a semantic map analysis of the CARPE registry data.Design, synthesis, and biological evaluation of indenoisoquinoline rexinoids with chemopreventive potentialEfficacy and Safety of Alitretinoin for Chronic Hand Eczema in Korean Patients.Systemic Treatment of Adult Atopic Dermatitis: A Review.Canadian hand dermatitis management guidelines.Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.Oral alitretinoin: a review of the clinical pharmacokinetics and pharmacodynamics.Guidelines for diagnosis, prevention and treatment of hand eczema--short version.Guidelines for diagnosis, prevention and treatment of hand eczema.Hand dermatitis: a review of clinical features, prevention and treatment.Guideline contact dermatitis: S1-Guidelines of the German Contact Allergy Group (DKG) of the German Dermatology Society (DDG), the Information Network of Dermatological Clinics (IVDK), the German Society for Allergology and Clinical Immunology (DGAKAlitretinoin: A Review in Severe Chronic Hand Eczema.Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum.Impact of systemic alitretinoin treatment on skin barrier gene and protein expression in patients with chronic hand eczema.Effectiveness of alitretinoin in severe chronic hand eczema: PASSION, a real-world observational study.Safety of alitretinoin for severe refractory chronic hand eczema: Clinical studies and postmarketing surveillance.Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin or ciclosporin A.Alitretinoin--its use in intractable hand eczema and other potential indications.Possible benefit of oral alitretinoin in T-lymphoproliferative diseases: a report of two patients with palmoplantar hyperkeratotic-rhagadiform skin changes and mycosis fungoides or Sézary syndrome.Treatment of Darier disease with oral alitretinoin.The outstanding record of clinical trials in the British Journal of Dermatology.Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy.Cost-of-illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany.Efficacy of treatment with oral alitretinoin in patient suffering from lichen simplex chronicus and severe atopic dermatitis of hands.ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients.9-cis-Retinoic acid induces a distinct regulatory dendritic cell phenotype that modulates murine delayed-type allergy.Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids.
P2860
Q24562747-1A7228F4-F63B-43BF-A4B2-548294FF95DAQ26851549-6BCA2AFF-C586-4237-93E2-0BD9861461C9Q27005835-02F68113-6086-4557-B74C-81C40501ECB0Q28390918-3CA837D0-0FA8-4AEB-BF47-D0BCD5B10E42Q30250205-732CF34A-596E-4402-94C1-AB888DC66FEBQ33616841-8C194294-5712-48EE-9DA3-D827CB01834DQ33683475-E074E9FB-F85C-469C-AF7D-62EA0EAB1B9BQ33710710-1DAB4E43-7A65-4130-B803-659B8C0178CCQ34620382-C1F16295-D7DE-4648-B303-8D75F71B9B93Q35599953-EC39F2C7-7C81-4699-9FAD-3F9BE72D2DCDQ35936420-EA5CA5E9-53F1-4098-977D-D9DE18766677Q36096584-8FEF2791-9C0D-4B21-8DFB-67993C5AA2ABQ36147795-CE6C0529-F6AB-4E0E-B8AA-4D0B52B4418EQ36370149-214BA90B-628A-4B3C-AA66-E796A50B88BBQ36758674-36549D11-BE78-4A6E-BBAA-F640B840A198Q36946020-0581A298-51FD-45CA-9B9B-ED1C31CFC985Q37679948-3FC474E4-C4CF-4926-8E6D-2F2E84FD7A32Q37810349-7B1816B5-94E1-45FD-9017-C29CABFA0333Q38027604-ADE6DB16-00F3-4969-847A-169D738EE0E1Q38040124-162C3A07-A2FD-4F8A-A658-EBE8AAB84564Q38339846-7C003D46-6569-4820-B6BE-B77FD08CE009Q38374914-93138C00-710D-4D49-B69A-F4789C75867FQ38446594-9BF34E90-E42C-45F8-8073-80C9FE473477Q38543062-8492A35D-2343-4CDB-B63A-C44C6F4C73A5Q38903240-1851E15D-4328-484E-A379-DA1DA9D1EEF2Q39013880-60F46F50-2A4D-462C-B7DF-059BA7CAB307Q39536814-F9FDBB6D-F612-4A65-9F94-1A9AC9A593B7Q40585781-D3356050-81C6-4C12-9960-009CA1DCAC29Q41053834-838003E9-A33D-4592-A013-D1032A7B9986Q42595395-3A074394-D6E0-4565-AD40-AF5C09A11783Q42595956-302EA866-A252-420D-B377-DFF015F212FEQ43270269-0B7C642B-5AE1-4553-AEE9-F3CE87380111Q43501959-1D03863D-130C-461E-A843-7FE80D8A0364Q43754969-D26503B5-EF12-4941-96B3-BC2625FE255DQ44830053-4C7825D4-C619-4C5E-8E64-8072B86234A7Q45289950-3D1CFDD0-1FFD-4FB6-B910-45D7F48EDFE9Q45942245-5FF95EBF-9780-4AC2-99D6-E4E3999BA992Q47849230-AA51C0E2-3B80-4ED9-9A8A-CBC15E003355Q48088564-468442D7-2413-4D1F-BE24-820302BB5DBCQ48156440-C72C28A8-0D2C-451C-821C-50C13E94C42C
P2860
Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Efficacy and safety of oral al ...... controlled, multicentre trial.
@ast
Efficacy and safety of oral al ...... controlled, multicentre trial.
@en
Efficacy and safety of oral al ...... controlled, multicentre trial.
@nl
type
label
Efficacy and safety of oral al ...... controlled, multicentre trial.
@ast
Efficacy and safety of oral al ...... controlled, multicentre trial.
@en
Efficacy and safety of oral al ...... controlled, multicentre trial.
@nl
prefLabel
Efficacy and safety of oral al ...... controlled, multicentre trial.
@ast
Efficacy and safety of oral al ...... controlled, multicentre trial.
@en
Efficacy and safety of oral al ...... controlled, multicentre trial.
@nl
P2093
P2860
P921
P1476
Efficacy and safety of oral al ...... controlled, multicentre trial.
@en
P2093
A Svensson
E Varjonen
F Cambazard
G B E Jemec
J Berth-Jones
P2860
P304
P356
10.1111/J.1365-2133.2008.08487.X
P407
P577
2008-02-21T00:00:00Z